Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders-Reference-Cited by-同舟云学术

Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders

Published:2017-05 Issue: Volume:235 Page:147-153
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Szmit Sebastian,Jurczak Wojciech,Zaucha Jan Maciej,Długosz-Danecka Monika,Sosnowska-Pasiarska Barbara,Chmielowska Ewa,Joks Monika,Drozd-Sokołowska Joanna,Knopińska-Posłuszny Wanda,Spychałowicz Wojciech,Kumiega Beata,Charliński Grzegorz,Morawska Marta,Słomian Grzegorz

Funder

Polish Lymphoma Research Group

East European Branch of International CardiOncology Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma;Hershman;J. Clin. Oncol.,2008

2. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study;Jurczak;Int. J. Cardiol.,2013

3. Evaluation and management of patients with heart disease and cancer: cardio-oncology;Herrmann;Mayo Clin. Proc.,2014

4. Individual prediction of heart failure among childhood cancer survivors;Chow;J. Clin. Oncol.,2015

5. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma;Szmit;J. Am. Soc. Hypertens.,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension—Real World Data of the Polish Lymphoma Research Group;Heart, Lung and Circulation;2024-05

2. Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer;Cancers;2021-09-01

3. Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building;Current Oncology Reports;2021-04-14

4. Cardioprotective effect of boswellic acids against doxorubicin induced myocardial infarction in rats;pakistan journal of pharmaceutical sciences;2021-01-01

5. Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin;Scientific Reports;2020-10-28